Drugs / MUSK pill
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04984954 | Jan 2021 → Dec 2023 | intermediate coronary syndrome, nonobstructive coronary artery disease | Shanghai Hutchison Pharmaceuticals Limited | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MUSK pill | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04984954 ↗ |